In last trading session, Medicus Pharma Ltd (NASDAQ:MDCX) saw 0.32 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $2.9 trading at -$0.2 or -6.45% at ring of the bell on the day assigns it a market valuation of $46.20M. That closing price of MDCX’s stock is at a discount of -208.28% from its 52-week high price of $8.94 and is indicating a premium of 37.93% from its 52-week low price of $1.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 233.23K if we extend that period to 3-months.

Medicus Pharma Ltd (NASDAQ:MDCX) trade information

Upright in the red during last session for losing -6.45%, in the last five days MDCX remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $2.9 price level, adding 10.77% to its value on the day. Medicus Pharma Ltd (NASDAQ:MDCX) showed a performance of -29.61% in past 30-days. Number of shares sold short was 0.11 million shares which calculate 0.25 days to cover the short interests.

In 2025, company’s earnings growth rate is likely to be around 11.21% while estimates for its earnings growth in next 5 years are of 5.68%.

Medicus Pharma Ltd (NASDAQ:MDCX)’s Major holders

Insiders are in possession of 44.95% of company’s total shares while institution are holding 19.20 percent of that, with stock having share float percentage of 34.88%. Investors also watch the number of corporate investors in a company very closely, which is 19.20% institutions for Medicus Pharma Ltd that are currently holding shares of the company.